# Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients

> **NCT02910219** · PHASE2 · COMPLETED · sponsor: **Sandra Swain** · enrollment: 53 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Crofelemer

## Key facts

- **NCT ID:** NCT02910219
- **Lead sponsor:** Sandra Swain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-31
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2022-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910219, "Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02910219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*